Reltio Doubles Down on India: Bengaluru Hub to Spearhead AI Innovation
In a strategic move to dominate the $50B+ enterprise data management market, Reltio, a leader in AI-powered data unification, has launched its largest global technology hub in Bengaluru. Located at RMZ Ecoworld, Bellandur, the facility will serve as the company’s R&D nerve center, focusing on real-time data intelligence, generative AI, and cloud-native solutions for Fortune 500 giants like Pfizer, HP, and AstraZeneca.
Why Bengaluru?
- Talent Magnet: Leverages India’s STEM talent pool to expand Reltio’s workforce by 70%, targeting 1,000+ roles in AI/ML, data engineering, and cybersecurity
- Strategic Partnerships: Collaborates with Accenture, TCS, Infosys, and Deloitte to co-innovate industry-specific data solutions
- Proximity to Fortune 500 GCCs: 400+ global enterprises in Bengaluru provide a testbed for scaling AI-driven use cases
From Data Chaos to Clarity: Reltio’s Innovation Blueprint
The Bengaluru hub will drive:
- AI-Powered Data Unification: Real-time cleansing and merging of multi-source data (CRM, IoT, transactional)
- GenAI Integration: Tools to automate compliance, enhance customer 360° views, and predict supply chain risks
- Cloud Scalability: Hybrid-cloud architectures for industries like pharma, automotive, and fintech
Leadership Vision
“India’s digital economy is a goldmine for data innovation,” said Manish Sood, CEO and Founder of Reltio. “Bengaluru’s ecosystem of top-tier engineers and Fortune 500 clients allows us to reimagine enterprise data strategies at unprecedented speed. This hub isn’t just about growth—it’s about shaping the future of AI-driven decision- making.”
Growth Metrics Fueling Expansion
- $155M ARR: Achieved record FY25 revenue, tripling in size since 2020
- 20% YoY Growth: Driven by demand for cloud data solutions in AI transformations.
- 44 Enterprise Clients: Each generating over $1M annually, including luxury automakers and global hotel chains
Case Study: Pharma Breakthrough
Reltio’s platform helped Pfizer unify clinical trial data across 30+ countries, reducing time-to-insights by 60% and accelerating drug approvals. The Bengaluru team developed AI models to flag data anomalies in real time
India’s Data Revolution: Reltio’s Strategic Edge
- For Enterprises: Deploy Reltio’s platform to turn fragmented data into a single source of truth
- For Talent: Join projects building ethical AI frameworks and patent-worthy tech
- For Partners: Co-create IP with Reltio’s APIs for verticals like healthcare and retail
The Road Ahead
- 2025 Goals: Onboard 10+ Fortune 100 clients and file 15 AI patents
- Sustainability Focus: Develop carbon footprint analytics tools for ESG compliance
Visit Our News section and follow us on LinkedIn and Twitter
